{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:50Z","timestamp":1788355370979,"version":"build-2803163510"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Alloimmune events such as the development of <jats:italic>de novo<\/jats:italic> donor-specific antibody (dnDSA), T cell-mediated rejection (TCMR), and antibody-mediated rejection (ABMR) are the primary contributors to kidney transplant failure in children. For decades, a creatinine-based estimated glomerular filtration rate (eGFR) has been the non-invasive gold standard biomarker for detecting clinically significant alloimmune events, but it suffers from low sensitivity and specificity, especially in smaller children and older allografts. Many clinically \u201cstable\u201d children (based on creatinine) will have alloimmune events known as \u201csubclinical acute rejection\u201d (based on biopsy) that merely reflect the inadequacy of creatinine-based estimates for alloimmune injury rather than a distinct phenotype from clinical rejection with allograft dysfunction. The poor biomarker performance of creatinine leads to many unnecessary surveillance and for-cause biopsies that could be avoided by integrating non-invasive biomarkers with superior sensitivity and specificity into current clinical paradigms. In this review article, we will present and appraise the current state-of-the-art in monitoring for alloimmune events in pediatric kidney transplantation. We will first discuss the current clinical standards for assessing the presence of alloimmune injury and predicting long-term outcomes. We will review principles of biomarker medicine and the application of comprehensive metrics to assess the performance of a given biomarker against the current gold standard. We will then highlight novel blood- and urine-based biomarkers (with special emphasis on pediatric biomarker studies) that have shown superior diagnostic and prognostic performance to the current clinical standards including creatinine-based eGFR. Finally, we will review some of the barriers to translating this research and implementing emerging biomarkers into common clinical practice, and present a transformative approach to using multiple biomarker platforms at different times to optimize the detection and management of critical alloimmune events in pediatric kidney transplant recipients.<\/jats:p>","DOI":"10.3389\/fped.2022.1087841","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:41:26Z","timestamp":1674193286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Biomarkers of alloimmune events in pediatric kidney transplantation"],"prefix":"10.3389","volume":"10","author":[{"given":"Kyle A.","family":"Deville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa031643","article-title":"Long-term survival of children with end-stage renal disease","volume":"350","author":"McDonald","year":"2004","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 annual data report: kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/TP.0b013e3181661695","article-title":"Influence of time of rejection on long-term graft survival in renal transplantation","volume":"85","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1681\/ASN.2018111101","article-title":"Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis","volume":"30","author":"Clayton","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/01.TP.0000441094.32217.05","article-title":"The severity of acute cellular rejection defined by banff classification is associated with kidney allograft outcomes","volume":"97","author":"Wu","year":"2014","journal-title":"Transplantation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/ajt.15299","article-title":"Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell\u2013mediated rejection","volume":"19","author":"Bouatou","year":"2019","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1034\/j.1399-3046.2002.02042.x","article-title":"Renal transplant outcomes in adolescents: a report of the North American pediatric renal transplant cooperative study","volume":"6","author":"Smith","year":"2002","journal-title":"Pediatr Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/TP.0b013e31823411d7","article-title":"Association between age and graft failure rates in young kidney transplant recipients","volume":"92","author":"Foster","year":"2011","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00857670","article-title":"Manifestations of renal allograft\u00a0rejection in small children receiving adult kidneys","volume":"4","author":"Bunchman","year":"1990","journal-title":"PediatrNephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1681\/ASN.2017010004","article-title":"Precision transplant medicine: biomarkers to the rescue","volume":"29","author":"Naesens","year":"2018","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/TP.0000000000001321","article-title":"Establishing biomarkers in transplant medicine: a critical review of current approaches","volume":"100","author":"Anglicheau","year":"2016","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1097\/TXD.0000000000001119","article-title":"Impact of subclinical borderline inflammation on kidney transplant outcomes","volume":"7","author":"Seifert","year":"2021","journal-title":"Transplant Direct"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14933","article-title":"Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation","author":"Seifert","year":"2018","journal-title":"Am J Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14627","article-title":"Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol","author":"Mehta","year":"2017","journal-title":"Am J Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1097\/TP.0000000000001163","article-title":"Subclinical rejection in renal transplantation: reappraised","volume":"100","author":"Mehta","year":"2016","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2215\/CJN.06300614","article-title":"Accuracy of different equations in estimating GFR in pediatric kidney transplant recipients","volume":"10","author":"de Souza","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"B18","year":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"10136","DOI":"10.3389\/ti.2022.10136","article-title":"Surrogate endpoints for late kidney transplantation failure","volume":"35","author":"Naesens","year":"2022","journal-title":"Transplant Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1111\/ajt.14349","article-title":"Belatacept-resistant rejection is associated with CD28(+) memory CD8 T cells","volume":"17","author":"Mathews","year":"2017","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1681\/ASN.2014121234","article-title":"Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients","volume":"26","author":"Hricik","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2215\/CJN.16421221","article-title":"Patterns in tacrolimus variability and association with De Novo donor-specific antibody formation in pediatric kidney transplant recipients","volume":"17","author":"Piburn","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/ajt.15011","article-title":"Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant","volume":"19","author":"Friedewald","year":"2019","journal-title":"Am J Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2215\/CJN.05530421","article-title":"Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients","volume":"16","author":"Park","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004324","article-title":"Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the trifecta study","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03840322","article-title":"Longitudinal evaluation of donor-derived cellfree DNA in pediatric kidney transplantation","author":"Dandamudi","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the assessing donor-derived cell-free DNA monitoring insights of kidney allografts with longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004212","article-title":"Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e13850","DOI":"10.1111\/petr.13850","article-title":"Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants","volume":"25","author":"Puliyanda","year":"2021","journal-title":"Pediatr Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.transproceed.2019.01.054","article-title":"Application of TruGraf v1: a novel molecular biomarker for managing kidney transplant recipients with stable renal function","volume":"51","author":"Marsh","year":"2019","journal-title":"Transplant Proc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e14145","DOI":"10.1111\/ctr.14145","article-title":"Avoiding surveillance biopsy: use of a noninvasive biomarker assay in a real-life scenario","volume":"35","author":"Ang","year":"2021","journal-title":"Clin Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1097\/TP.0b013e3181a66b3e","article-title":"Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines\/chemokines in urine","volume":"87","author":"Hu","year":"2009","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/TP.0000000000001304","article-title":"Six-month urinary CCL2 and CXCL10 levels predict long-term renal allograft outcome","volume":"100","author":"Hirt-Minkowski","year":"2016","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/j.1600-6143.2011.03680.x","article-title":"Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection","volume":"11","author":"Jackson","year":"2011","journal-title":"Am J Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1111\/ajt.15959","article-title":"Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection","volume":"20","author":"Tinel","year":"2020","journal-title":"Am J Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082325","article-title":"Clinical and analytical validation of a novel urine-based test for the detection of allograft rejection in renal transplant patients","volume":"9","author":"Nolan","year":"2020","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15752","article-title":"Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies","author":"Madill-Thomsen","year":"2019","journal-title":"Am J Transplant"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1097\/TP.0000000000002310","article-title":"Donor-specific antibody surveillance and graft outcomes in pediatric kidney transplant recipients","volume":"102","author":"Engen","year":"2018","journal-title":"Transplantation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/ajt.14169","article-title":"Relationship among viremia\/viral infection, alloimmunity, and nutritional parameters in the first year after pediatric kidney transplantation","volume":"17","author":"Ettenger","year":"2017","journal-title":"Am J Transplant"},{"key":"B45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the assessing donor-derived cell-free DNA monitoring insights of kidney allografts with longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/ajt.13677","article-title":"Early low urinary CXCL9 and CXCL10 might predict immunological quiescence in clinically and histologically stable kidney recipients","volume":"16","author":"Rabant","year":"2016","journal-title":"Am J Transplant"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/ajt.16336","article-title":"Validity and utility of urinary CXCL10\/Cr immune monitoring in pediatric kidney transplant recipients","volume":"21","author":"Blydt-Hansen","year":"2021","journal-title":"Am J Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/TP.0000000000002026","article-title":"Analysis of biomarkers within the initial 2 years posttransplant and 5-year kidney transplant outcomes: results from clinical trials in organ transplantation-17","volume":"102","author":"Faddoul","year":"2018","journal-title":"Transplantation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1681\/ASN.2015010062","article-title":"Proteinuria as a noninvasive marker for renal allograft histology and failure: an observational cohort study","volume":"27","author":"Naesens","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/ajt.16907","article-title":"Effectiveness of T cell-mediated rejection therapy: a systematic review and meta-analysis","volume":"22","author":"Ho","year":"2022","journal-title":"Am J Transplant"},{"key":"B51","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/ajt.16883","article-title":"The negative impact of T cell-mediated rejection on renal allograft survival in the modern era","volume":"22","author":"Rampersad","year":"2022","journal-title":"Am J Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/ajt.13572","article-title":"Using molecular phenotyping to guide improvements in the histologic diagnosis of T cell-mediated rejection","volume":"16","author":"Reeve","year":"2016","journal-title":"Am J Transplant"},{"key":"B53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1314376","article-title":"Kidney transplantation in children","volume":"371","author":"Dharnidharka","year":"2014","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1681\/ASN.2016080858","article-title":"Moving biomarkers toward clinical implementation in kidney transplantation","volume":"28","author":"Menon","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1399-0012.2005.00377.x","article-title":"Reproducibility of the Banff classification in subclinical kidney transplant rejection","volume":"19","author":"Veronese","year":"2005","journal-title":"Clin Transplant"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e13597-e","DOI":"10.1111\/petr.13597","article-title":"Kidney transplant practice patterns and outcome benchmarks over 30 years: the 2018 report of the NAPRTCS","volume":"23","author":"Chua","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1397-3142.2003.00122.x","article-title":"Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children","volume":"8","author":"Birk","year":"2004","journal-title":"Pediatr Transplant"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/ALN.0b013e3181d47604","article-title":"Statistical evaluation of a biomarker","volume":"112","author":"Ray","year":"2010","journal-title":"J Am Soc Anesth"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00467-017-3712-6","article-title":"Biomarkers to detect rejection after kidney transplantation","volume":"33","author":"Dharnidharka","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba2501","article-title":"A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection","volume":"12","author":"Yang","year":"2020","journal-title":"Sci Transl Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1399-3046.2005.00235.x","article-title":"Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients","volume":"9","author":"Podracka","year":"2005","journal-title":"Pediatr Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/ajt.14933","article-title":"Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation","volume":"18","author":"Seifert","year":"2018","journal-title":"Am J Transplant"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e13202","DOI":"10.1111\/petr.13202","article-title":"Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection","author":"Mincham","year":"2018","journal-title":"Pediatr Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00467-011-1969-8","article-title":"Surveillance biopsies in children post-kidney transplant","volume":"27","author":"Birk","year":"2012","journal-title":"Pediatric Nephrol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/ajt.14888","article-title":"Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?","volume":"19","author":"Nankivell","year":"2019","journal-title":"Am J Transplant"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/j.1600-6143.2006.01436.x","article-title":"The significance of subclinical rejection and the value of protocol biopsies","volume":"6","author":"Nankivell","year":"2006","journal-title":"Am J Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ndt\/gfz091","article-title":"The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney\u00a0transplantation","volume":"35","author":"Gielis","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"Fso295","DOI":"10.4155\/fsoa-2017-0140","article-title":"Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature","volume":"4","author":"Khier","year":"2018","journal-title":"Future Sci OA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e14258","DOI":"10.1111\/petr.14258","article-title":"Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection","volume":"26","author":"Steggerda","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/ajt.14224","article-title":"Orthogonal comparison of molecular signatures of kidney transplants with subclinical and clinical acute rejection: equivalent performance is agnostic to both technology and platform","volume":"17","author":"Kurian","year":"2017","journal-title":"Am J Transplant"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/ajt.15197","article-title":"The clinical and pathological significance of borderline T cell-mediated rejection","volume":"19","author":"Nankivell","year":"2019","journal-title":"Am J Transplant"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001244","article-title":"Design and methods of the validating injury to the renal transplant using urinary signatures (VIRTUUS) study in children","volume":"7","author":"Kumar","year":"2021","journal-title":"Transplant Direct"},{"key":"B73","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/TP.0b013e3181e6424d","article-title":"Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts","volume":"90","author":"Ho","year":"2010","journal-title":"Transplantation"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186889","article-title":"Urinary biomarkers for diagnosis and prediction of acute kidney allograft rejection: a systematic review","volume":"21","author":"Guzzi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1600-6143.2009.02645.x","article-title":"Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis","volume":"9","author":"Schaub","year":"2009","journal-title":"Am J Transplant"},{"key":"B76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.TP.0000442776.40295.73","article-title":"Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months","volume":"98","author":"Ho","year":"2014","journal-title":"Transplantation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/TP.0b013e31826690fd","article-title":"Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss","volume":"95","author":"Ho","year":"2013","journal-title":"Transplantation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/TP.0000000000000419","article-title":"Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation","volume":"99","author":"Blydt-Hansen","year":"2015","journal-title":"Transplantation"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/ajt.12284","article-title":"Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling","volume":"13","author":"Keslar","year":"2013","journal-title":"Am J Transplant"},{"key":"B80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.2215\/CJN.14010820","article-title":"Urinary cell mRNA profiles predictive of human kidney allograft Status","volume":"16","author":"Lubetzky","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/j.1523-1755.2004.00663.x","article-title":"Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine","volume":"65","author":"Tatapudi","year":"2004","journal-title":"Kidney Int"},{"key":"B83","volume-title":"A novel microfluidic-based platform that enables automated, operator-independent and sensitive monitoring of renal allograft injury in the clinic. Pediatric transplantation","author":"Seifert","year":"2017"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1087841\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:41:32Z","timestamp":1674193292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1087841\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":83,"alternative-id":["10.3389\/fped.2022.1087841"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1087841","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"article-number":"1087841"}}